Clinical Trials Logo

Clinical Trial Summary

To explore the differences in the green channel process of stroke in various regions of the same province, to target and shorten the time delay of emergency process, and to explore the key technologies of endovascular treatment of acute ischemic stroke. To investigate the use and embolectomy effect of Reco, the first embolectomy stent in China, in economically developed areas. Health economic assessment (cost-benefit analysis) of ischemic stroke patients in various regions of the province.


Clinical Trial Description

The Reco Embolectomy Stent is indicated for patients who cannot be treated with intravenous tissue activator (IVt-PA) or who have failed IVt-PA therapy and is intended to remove thrombus from a large intracranial vessel in patients with ischemic stroke to restore blood flow. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05166733
Study type Observational
Source The First People's Hospital of Changzhou
Contact Jie Cao
Phone 13646125766
Email mayday509@163.com
Status Not yet recruiting
Phase
Start date December 2021
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01642056 - EPI-743 for Metabolism or Mitochondrial Disorders Phase 1/Phase 2
Completed NCT01212419 - SWC on aEEG in Post-surgical Neonates on Morphine and Midazolam N/A
Terminated NCT04763603 - Assessment of Plaque Vulnerability Using a Novel Technique: Multi-spectral PhotoAcoustic Imaging.
Recruiting NCT05539196 - A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
Not yet recruiting NCT05089786 - Echo-Focusing in Patients With Treatment-Resistant Neurologic and Psychiatric Indications (EF001) N/A
Completed NCT00296140 - Implementing Evidence in the Detection and Treatment of Post Stroke Depression N/A
Completed NCT04660019 - Combined Scalp and Ear Acupuncture in Patients With Proton Pump Inhibitor- Dependent Gastroesophageal Reflux Disease N/A